PLEASANTON, Calif., Nov. 24 Thoratec Corporation(Nasdaq: THOR), a world leader in device-based mechanical circulatory supporttherapies to save, support and restore falling hearts, said today that it willbe participating in the 20th Annual Piper Jaffray Heath Care Conference onWednesday, December 3.
Gary Burbach, president and chief executive officer, will provide anupdate on the company, beginning at 1 p.m., Eastern Standard Time (10 a.m.,Pacific Standard Time).
The presentation will be available through the conference website athttp://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=THOR&item_id=2021265or on the company's website at http://www.thoratec.com.
Thoratec is a world leader in therapies to address advanced-stage heartfailure. The company's product lines include the Thoratec(R) VAD (VentricularAssist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) withnearly 12,000 devices implanted in patients suffering from heart failure.Additionally, its International Technidyne Corporation (ITC) division suppliespoint-of-care blood testing and skin incision products. Thoratec isheadquartered in Pleasanton, California. For more information, visit thecompany's web sites at http://www.thoratec.com or http://www.itcmed.com.
SOURCE Thoratec Corporation